Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: Dec. 21, 2023
Epstein-Barr
virus
(EBV)
is
a
prevalent
oncogenic
estimated
to
infect
greater
than
90%
of
the
world's
population.
Following
initial
infection,
it
establishes
latency
in
host
B
cells.
EBV
has
developed
multitude
techniques
avoid
detection
by
immune
system
and
establish
lifelong
infection.
T
cells,
as
important
contributors
cell-mediated
immunity,
make
an
attractive
target
for
these
immunoevasive
strategies.
Indeed,
evolved
numerous
mechanisms
modulate
cell
responses.
For
example,
can
augment
expression
programmed
death
ligand-1
(PD-L1),
which
inhibits
function,
downregulates
interferon
response,
strong
impact
on
regulation.
It
also
modulates
interleukin
secretion
influence
major
histocompatibility
complex
(MHC)
presentation.
In
addition
facilitating
persistent
immunoregulatory
have
significant
implications
evasion
response
tumor
This
review
dissects
through
avoids
cells
discusses
how
play
into
survival.
concludes
with
overview
cancer
treatments
targeting
setting
EBV-associated
malignancy.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Jan. 10, 2024
Abstract
Epstein-Barr
virus
(EBV)
latent
membrane
protein
1
(LMP1)
drives
viral
B
cell
transformation
and
oncogenesis.
LMP1’s
transforming
activity
depends
on
its
C-terminal
activation
region
2
(CTAR2),
which
induces
NF-κB
JNK
by
engaging
TNF
receptor-associated
factor
6
(TRAF6).
The
mechanism
of
TRAF6
recruitment
to
LMP1
role
in
signalling
remains
elusive.
Here
we
demonstrate
that
interacts
directly
with
a
binding
motif
within
CTAR2.
Functional
NMR
studies
supported
molecular
modeling
provide
insight
into
the
architecture
LMP1-TRAF6
complex,
differs
from
CD40-TRAF6.
direct
is
essential
for
CTAR2
survival
LMP1-driven
lymphoma.
Disruption
complex
inhibitory
peptides
interferes
EBV-transformed
cells.
In
this
work,
identify
as
critical
virus-host
interface
validate
interaction
potential
therapeutic
target
EBV-associated
cancer.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Feb. 15, 2024
The
host
defence
responses
play
vital
roles
in
viral
infection
and
are
regulated
by
complex
interactive
networks.
immune
system
recognizes
pathogens
through
the
interaction
of
pattern-recognition
receptors
(PRRs)
with
pathogen-associated
molecular
patterns
(PAMPs).
As
a
PRR
mainly
cytoplasm,
cyclic
GMP-AMP
synthase
(cGAS)
senses
binds
virus
DNA
subsequently
activates
stimulator
interferon
genes
(STING)
to
trigger
series
intracellular
signalling
cascades
defend
against
invading
pathogenic
microorganisms.
Integrated
omic
functional
analyses
identify
cGAS-STING
pathway
regulating
various
cellular
controlling
infections.
Aside
from
its
most
common
function
inflammation
type
I
interferon,
growing
body
evidence
suggests
that
axis
is
closely
associated
responses,
such
as
oxidative
stress,
autophagy,
endoplasmic
reticulum
which
have
major
impacts
on
physiological
homeostasis.
Interestingly,
these
dual
regulation
clearance
viruses.
Here,
we
outline
recent
insights
into
inflammation,
autophagy
stress
discuss
their
interactions
A
detailed
understanding
cGAS-STING-mediated
potential
antiviral
effects
contributes
revealing
pathogenesis
certain
viruses
sheds
light
effective
solutions
for
therapy.
Periodontology 2000,
Journal Year:
2024,
Volume and Issue:
96(1), P. 170 - 184
Published: April 20, 2024
Abstract
This
review
focuses
on
three
major
aspects
of
oncoviruses'
role
in
cancer
development.
To
begin,
we
discuss
their
geographic
distribution,
revealing
that
seven
oncoviruses
cause
20%
all
human
cancers
worldwide.
Second,
investigate
the
primary
carcinogenic
mechanisms,
looking
at
how
these
oncogenic
viruses
can
induce
cellular
transformation,
angiogenesis,
and
local
systemic
inflammation.
Finally,
possibility
SARS‐CoV‐2
infection
reactivating
latent
oncoviruses,
which
could
increase
risk
further
disease.
The
development
oncovirus
vaccines
holds
great
promise
for
reducing
burden.
Many
unanswered
questions
about
host
environmental
cofactors
contribute
to
prevention
remain,
ongoing
research
is
attempting
address.
Cancers,
Journal Year:
2024,
Volume and Issue:
16(17), P. 2997 - 2997
Published: Aug. 28, 2024
Oral
squamous
cell
carcinoma
(OSCC)
is
the
most
common
head
and
neck
cancer.
Although
oral
cavity
an
easily
accessible
area
for
visual
examination,
OSCC
more
often
detected
at
advanced
stage.
The
global
prevalence
of
around
6%,
with
increasing
trends
posing
a
significant
health
problem
due
to
increase
in
morbidity
mortality.
microbiome
has
been
target
numerous
studies,
findings
highlighting
role
dysbiosis
developing
OSCC.
Dysbiosis
can
significantly
pathobionts
(bacteria,
viruses,
fungi,
parasites)
that
trigger
inflammation
through
their
virulence
pathogenicity
factors.
In
contrast,
chronic
bacterial
contributes
development
Pathobionts
also
have
other
effects,
such
as
impact
on
immune
system,
which
alter
responses
contribute
pro-inflammatory
environment.
Poor
hygiene
carbohydrate-rich
foods
risk
factors
mechanisms
are
not
yet
fully
understood
remain
frequent
research
topic.
For
this
reason,
narrative
review
concentrates
issue
potential
cause
OSCC,
well
underlying
involved.
Cells,
Journal Year:
2022,
Volume and Issue:
11(19), P. 3043 - 3043
Published: Sept. 28, 2022
Innate
immune
mechanisms
initiate
responses
via
pattern-recognition
receptors
(PRRs).
Cyclic
GMP-AMP
synthase
(cGAS),
a
member
of
the
PRRs,
senses
diverse
pathogenic
or
endogenous
DNA
and
activates
innate
signaling
pathways,
including
expression
stimulator
interferon
genes
(STING),
type
I
interferon,
other
inflammatory
cytokines,
which,
in
turn,
instructs
adaptive
response
development.
This
groundbreaking
discovery
has
rapidly
advanced
research
on
host
defense,
cancer
biology,
autoimmune
disorders.
Since
cGAS/STING
enormous
potential
eliciting
an
response,
understanding
its
functional
regulation
is
critical.
As
most
widespread
efficient
regulatory
mode
cGAS-STING
pathway,
post-translational
modifications
(PTMs),
such
as
covalent
linkage
groups
to
amino
acid
chains,
are
generally
considered
mechanism
for
protein
destruction
renewal.
In
this
review,
we
discuss
transduction
related
diseases
focus
current
different
modalities
PTMs
control
cGAS-STING-triggered
responses.
Proceedings of the National Academy of Sciences,
Journal Year:
2023,
Volume and Issue:
120(20)
Published: May 8, 2023
Latent
Epstein–Barr
virus
(EBV)
infection
promotes
undifferentiated
nasopharyngeal
carcinomas
(NPCs)
in
humans,
but
the
mechanism(s)
for
this
effect
has
been
difficult
to
study
because
EBV
cannot
transform
normal
epithelial
cells
vitro
and
genome
is
often
lost
when
NPC
are
grown
culture.
Here
we
show
that
latent
protein,
LMP1
(Latent
membrane
protein
1),
induces
cellular
proliferation
inhibits
spontaneous
differentiation
of
telomerase-immortalized
oral
keratinocytes
(NOKs)
growth
factor-deficient
conditions
by
increasing
activity
Hippo
pathway
effectors,
YAP
(Yes-associated
protein)
TAZ
(Transcriptional
coactivator
with
PDZ-binding
motif).
We
demonstrate
enhances
NOKs
both
decreasing
pathway-mediated
serine
phosphorylation
Src
kinase-mediated
Y357
YAP.
Furthermore,
knockdown
sufficient
reduce
promote
EBV-infected
NOKs.
find
also
required
LMP1-induced
epithelial-to-mesenchymal
transition.
Importantly,
ibrutinib
(an
FDA-approved
BTK
inhibitor
blocks
through
an
off-target
effect)
restores
at
clinically
relevant
doses.
These
results
suggest
contributes
development
NPC.
Frontiers in Virology,
Journal Year:
2023,
Volume and Issue:
3
Published: March 6, 2023
The
burden
of
malignancy
related
to
viral
infection
is
increasing
in
Sub-Saharan
Africa
(SSA).
In
2018,
approximately
2
million
new
cancer
cases
worldwide
were
attributable
infection.
Prevention
or
treatment
these
infections
could
reduce
by
23%
less
developed
regions
and
about
7%
regions.
Contemporaneous
increases
longevity
changes
lifestyle
have
contributed
the
SSA.
African
hospitals
are
reporting
more
(e.g.,
cervical
women
stomach
liver
men).
SSA
populations
also
elevated
underlying
prevalence
compared
other
Of
10
infectious
agents
identified
as
carcinogenic
International
Agency
for
Research
on
Cancer,
six
viruses:
hepatitis
B
C
viruses
(HBV
HCV,
respectively),
Epstein-Barr
virus
(EBV),
high-risk
types
human
papillomavirus
(HPV),
Human
T-cell
lymphotropic
type
1
(HTLV-1),
Kaposi’s
sarcoma
herpesvirus
(KSHV,
known
8,
HHV-8).
immunodeficiency
(HIV)
facilitates
oncogenesis.
EBV
associated
with
lymphomas
nasopharyngeal
carcinoma;
HBV
HCV
hepatocellular
KSHV
causes
sarcoma;
HTLV-1
leukemia
lymphoma;
HPV
carcinoma
oropharynx
anogenital
squamous
cell
cancer.
HIV-1,
which
has
greatest
global
burden,
been
linked
risk
through
immunologic
dysregulation
clonal
hematopoiesis.
Public
health
approaches
prevent
infection,
such
vaccination,
safer
injection
techniques,
screening
blood
products,
antimicrobial
treatments
sexual
practices
Africa.
SSA,
inequalities
access
exacerbated
perception
taboo.
National
level
registries,
strategies
detection
public
messaging
should
be
prioritized
SSA’s
battle
against
malignancy.
this
review,
we
discuss
impact
a
focus
regional
epidemiology.
Russian Journal of Infection and Immunity,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 16, 2025
Abstract
Introduction.
According
to
international
studies,
the
Epstein-Barr
virus
(EBV)
isolates
from
individuals
infected
with
human
immunodeficiency
(HIV)
are
characterized
by
specific
molecular
genetic
features
compared
immunocompetent
individuals.
In
Russia,
no
studies
have
yet
been
conducted
assessing
EBV
diversity
in
HIV-patients.
The
aim
of
study
is
assess
adult
HIV-patients
Nizhny
Novgorod
region.
Materials
and
methods.
derived
blood
leukocytes
138
HIV-infected
patients
aged
20–69
years
(HIV(+)
group)
68
HIV-uninfected
sex-
age-matched
(HIV(-)
were
studied.
For
differential
detection
EBV-1/EBV-2,
there
used
PCR
variant
electrophoretic
amplification
products
agarose
gel.
Nucleotide
sequences
C-terminal
fragment
LMP-1
gene
determined
Sanger
sequencing.
Phylogenetic
analysis
was
performed
using
MEGA
X
software.
Results.
typical
pattern
region
adults
HIV(-)
group,
only
EBV-1
detected.
HIV(+)
group
rate
88.2±3.4%,
EBV-2
–
5.4±2.3%,
EBV-1+VEB-2
6.4±
2.6%
cases.
strain
structure
based
on
classification
R.
Edwards
et
al.
five
variants
identified:
B95-8,
China
1,
Med-,
NC
Alaskan,
among
which
B95-8
dominant.
However,
their
frequency
did
not
differ
between
groups.
general,
HIV
infection,
appearance
recombinant
variants,
a
wider
range
deletions,
prominent
variability
tandem
repeat
presence
modified
motifs
point
amino
acid
substitutions
therein
noted,
57
described
that
previously
found
Conclusion.
first
time
carried
out.
results
obtained
build
up
basis
for
prospective
relationship
clinical
laboratory
characteristics
EBV+HIV
co-infection
heterogeneity
population
at
level
types,
subvariants.